Advertisement

Vital Signs: Who will lead FDA under Trump?

By Adam Rubenfire  |  December 08, 2016

Rumors are swirling about who President-elect Donald Trump may choose to lead the Food and Drug Administration, including a venture capitalist and a former agency official.

New Medicare data show steep increases in drug prices

New Medicare data show steep increases in drug prices

By Shelby Livingston and Art Golab  |  December 07, 2016

The CMS on Wednesday released data on the price history of 5,000 prescription drugs over five years, shedding light on the fastest rising source of healthcare costs in recent years.

Pfizer fined for hiking epilepsy drug price 2,600%

Pfizer fined for hiking epilepsy drug price 2,600%

By Associated Press  |  December 07, 2016

British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record $112.7 million Wednesday for increasing the cost of an epilepsy drug by as much as 2,600%.

Can't buy love? Drug price hikes put sex beyond reach

Can't buy love? Drug price hikes put sex beyond reach

By Associated Press  |  December 05, 2016

Imagine not being able to afford one of life's great pleasures — sex. That's true for many older couples, doctors say. Soaring prices for prescription medicines for impotence and other problems have put the remedies out of reach for some.

Pfizer to use IBM Watson to devise immunotherapies for cancer

Pfizer to use IBM Watson to devise immunotherapies for cancer

By Adam Rubenfire  |  December 01, 2016

Pfizer claims to be one of the first companies to use Watson's abilities for drug discovery and the first to use it for immuno-oncology—lucrative types of drugs that could be a major revenue source for Pfizer if its research succeeds.

Juno Therapeutics halts study after more patient deaths

By Associated Press  |  November 23, 2016

Juno Therapeutics is halting the study of an experimental leukemia treatment for a second time after the death of two more patients. Two patients were reported dead in the closely watched drug trial in July.

EpiPen manufacturer will be a no-show at Senate hearing

By Associated Press  |  November 21, 2016

Pharmaceutical company Mylan is refusing to testify at a congressional hearing next week on a settlement between the company and the Justice Department over its life-saving EpiPen.

Pharma bad boy celebrates Trump win by releasing some rap

Pharma bad boy celebrates Trump win by releasing some rap

By Modern Healthcare  |  November 19, 2016

Martin Shkreli promised last month to release Wu-Tang Clan's “Once Upon a Time in Shaolin” if Donald Trump took the White House. He made good on promise the day after the election by playing snippets of the album during a live Periscope video posted on Twitter.

Ex-Valeant and specialty pharmacy execs charged in kickback scheme

By Erica Teichert  |  November 17, 2016

Federal prosecutors on Thursday charged a former Valeant Pharmaceuticals executive and the ex-CEO of a specialty pharmacy for masterminding a multimillion fraud and kickback scheme that promoted the pharmacy's business for their own personal gain.

AMA embraces value-based drug pricing

AMA embraces value-based drug pricing

By Adam Rubenfire  |  November 15, 2016

The American Medical Association joined the growing number of clinical organizations calling for value-based pricing for medications.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.